Erytech Pharma SA (ERYP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Erytech Pharma SA (ERYP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7838
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are intended for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, pancreatic cancer and non hodgkin lymphoma, among others. Erytech provides pipeline products such as eryasp, erymet, erymmune, and others. The company also develops other product candidates which uses encapsulated enzymes to induce tumor starvation. Its technology platform ERYCAPS uses red blood cells to discover therapeutic compounds. Erytech is headquartered in Lyon, France.

Erytech Pharma SA (ERYP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Erytech Pharma SA, Medical Equipment, Deal Details 10
Venture Financing 10
Erytech Pharma Raises USD3.95 Million in Venture Financing 10
Erytech Pharma Secures USD19.24 Million in Venture Funding 11
Equity Offering 12
Erytech Pharma Raises USD125 Million in IPO of American Depository Shares 12
Erytech Pharma Raises USD15.9 Million in Private Placement of Shares 14
Erytech Pharma Raises USD74.7 Million in Private Placement of Shares 15
Erytech Pharma Raises USD11 Million in Private Placement of Shares 16
Erytech Pharma Raises USD27 Million in Private Placement of Shares 17
Erytech Pharma Raises USD38 Million in Private Placement of Shares 19
Erytech Pharma SA – Key Competitors 20
Erytech Pharma SA – Key Employees 21
Erytech Pharma SA – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Sep 10, 2018: ERYTECH Pharma announces first half of 2018 financial results 23
May 14, 2018: Erytech Reports First Quarter 2018 Financial Results and Provides Business Update 25
Mar 12, 2018: ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 26
Sep 11, 2017: ERYTECH Reports First Half 2017 Financial Results and Provides Business Update 28
May 18, 2017: ERYTECH Provides Business Update and Financial Highlights For Q1 2017 31
Corporate Communications 32
May 14, 2018: Erytech Strengthens Executive Team With the Appointment of Alex Dusek as VP of Commercial Strategy 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Erytech Pharma SA, Medical Equipment, Key Facts, 2017 2
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Deals By Market, 2012 to YTD 2018 8
Erytech Pharma SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Erytech Pharma Raises USD3.95 Million in Venture Financing 10
Erytech Pharma Secures USD19.24 Million in Venture Funding 11
Erytech Pharma Raises USD125 Million in IPO of American Depository Shares 12
Erytech Pharma Raises USD15.9 Million in Private Placement of Shares 14
Erytech Pharma Raises USD74.7 Million in Private Placement of Shares 15
Erytech Pharma Raises USD11 Million in Private Placement of Shares 16
Erytech Pharma Raises USD27 Million in Private Placement of Shares 17
Erytech Pharma Raises USD38 Million in Private Placement of Shares 19
Erytech Pharma SA, Key Competitors 20
Erytech Pharma SA, Key Employees 21
Erytech Pharma SA, Subsidiaries 22

List of Figures
Erytech Pharma SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Erytech Pharma SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Erytech Pharma SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Erytech Pharma SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Erytech Pharma SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Erytech Pharma SA (ERYP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bank Sepah:企業の戦略・SWOT・財務情報
    Bank Sepah - Strategy, SWOT and Corporate Finance Report Summary Bank Sepah - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Svenska Cellulosa Aktiebolaget:企業のM&A・事業提携・投資動向
    Svenska Cellulosa Aktiebolaget - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Cellulosa Aktiebolaget Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Melia Hotels International SA:企業の戦略・SWOT・財務情報
    Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report Summary Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Maxim Power Corp.:企業の発電所・SWOT分析2018
    Maxim Power Corp. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析
    Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Columbus Life Insurance Company:企業の戦略的SWOT分析
    Columbus Life Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Advanced Technology Company (ATC):企業の財務・戦略的SWOT分析
    Advanced Technology Company (ATC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Hexion Inc.:企業の戦略・SWOT・財務情報
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • LVMH Moet Hennessy Louis Vuitton SA:戦略・SWOT・企業財務分析
    LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report Summary LVMH Moet Hennessy Louis Vuitton SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tianda Pharmaceuticals Ltd (455):企業の財務・戦略的SWOT分析
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • Becton Dickinson and Co (BDX)-医療機器分野:企業M&A・提携分析
    Summary Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instrument. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management …
  • Imperial College London-医療機器分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Haitong Securities Co., Ltd.:企業の戦略・SWOT・財務情報
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • FirstEnergy Corp (FE):電力:M&Aディール及び事業提携情報
    Summary FirstEnergy Corp. (FirstEnergy) is a diversified energy company, which generates, transmits, distributes and sells electricity. The company’s regulated distribution companies form one of the nation's largest investor-owned electric systems. Its major electricity generating assets include coa …
  • National Bank of Canada:企業のM&A・事業提携・投資動向
    National Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It offers cosmeceutical programs such as development of anti-aging and depigmenting agents, …
  • Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …
  • Stiefel Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Stiefel Laboratories Inc (Stiefel Laboratories), a subsidiary of GlaxoSmithKline Plc is a healthcare products provider that develops products for sun care, dry skin and clear skin. The company also offers research and development, manufacture, marketing and distribution of prescription medic …
  • Florida Power & Light Co:企業の発電所・SWOT分析2018
    Florida Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Fubon Financial Holding Co Ltd:戦略・SWOT・企業財務分析
    Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆